During the past decade, Berkshire Cancer Centre at Royal Berkshire Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berkshire Cancer Centre at Royal Berkshire Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 5 trials, followed by "Medical Research Council" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Aberdeen Royal Infirmary" with 1 trials sponsored and "Anglo Celtic Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berkshire Cancer Centre at Royal Berkshire Hospital" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Lymphoma Trials Office" with 1 trials as a collaborator and "Medical Research Council" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Berkshire Cancer Centre at Royal Berkshire Hospital" are "Breast Cancer" (4 trials), "Lung Cancer" (3 trials), "Testicular Germ Cell Tumor" (3 trials), "Extragonadal Germ Cell Tumor" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "Berkshire Cancer Centre at Royal Berkshire Hospital" in a lesser frequency.

Most popular intervention types in "Berkshire Cancer Centre at Royal Berkshire Hospital" are "Drug" (15 trials), "Procedure" (12 trials), "Biological" (6 trials), "Radiation" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (5 trials), "quality-of-life assessment" (5 trials), "cisplatin" (4 trials), "cyclophosphamide" (4 trials) and "radiation therapy" (4 trials). Other intervention names were less common.

The vast majority of trials in "Berkshire Cancer Centre at Royal Berkshire Hospital" are 11 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Berkshire Cancer Centre at Royal Berkshire Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Berkshire Cancer Centre at Royal Berkshire Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Berkshire Cancer Centre at Royal Berkshire Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".